PDCD4 anticorps (AA 1-260)

N° du produit ABIN7164693

Détail du produit anti-PDCD4 anticorps

Antigène: PDCD4 (Programmed Cell Death 4 (PDCD4))

Épitope: AA 1-260

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PDCD4 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunoprecipitation (IP)

Réactivité croisée: Humain

Purification: Antigen Affinity Purified

Immunogène: Recombinant Human Programmed cell death protein 4 protein (1-260AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: WB:1:1000-1:5000, IP:1:200-1:2000,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur PDCD4

Antigène: PDCD4 (Programmed Cell Death 4 (PDCD4))

Autre désignation: PDCD4 (PDCD4 Produits)

Synonymes: anticorps H731, anticorps D19Ucla1, anticorps Ma3, anticorps Tis, anticorps Dug, anticorps cb45, anticorps pdcd4, anticorps sb:cb45, anticorps wu:fc84b08, anticorps h731, anticorps MGC69337, anticorps PDCD4, anticorps wu:fa55g03, anticorps wu:fb08a11, anticorps wu:fe01a02, anticorps zgc:66311, anticorps programmed cell death 4, anticorps programmed cell death 4b, anticorps programmed cell death 4 L homeolog, anticorps programmed cell death 4 (neoplastic transformation inhibitor), anticorps programmed cell death 4a, anticorps PDCD4, anticorps Pdcd4, anticorps pdcd4b, anticorps pdcd4.L, anticorps pdcd4, anticorps pdcd4a

Sujet:

Background: Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA .

Aliases: Death up-regulated gene protein antibody, Dug antibody, H731 antibody, Ma3 antibody, MGC33046 antibody, MGC33047 antibody, Neoplastic transformation inhibitor antibody, Neoplastic transformation inhibitor protein antibody, Nuclear antigen H731 antibody, Nuclear antigen H731 like antibody, Nuclear antigen H731 like protein antibody, Nuclear antigen H731-like antibody, PDCD 4 antibody, Pdcd4 antibody, PDCD4_HUMAN antibody, Programmed cell death 4 antibody, programmed cell death 4 (neoplastic transformation inhibitor) antibody, Programmed cell death protein 4 antibody, Protein 197/15a antibody, Protein MA-3 antibody, Tis antibody, Topoisomerase-inhibitor suppressed protein antibody

UniProt: Q53EL6